American Century Companies Inc. bought a new stake in InMode Ltd. (NASDAQ:INMD - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 17,907 shares of the healthcare company's stock, valued at approximately $299,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new stake in InMode in the fourth quarter valued at about $87,000. Farther Finance Advisors LLC boosted its stake in shares of InMode by 26.2% in the 4th quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company's stock valued at $93,000 after purchasing an additional 1,154 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of InMode by 6.2% during the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company's stock valued at $169,000 after purchasing an additional 579 shares during the last quarter. DGS Capital Management LLC acquired a new position in InMode during the 3rd quarter worth approximately $182,000. Finally, HighTower Advisors LLC bought a new position in InMode in the 4th quarter valued at approximately $180,000. 68.04% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have recently issued reports on INMD. Jefferies Financial Group lowered their price target on shares of InMode from $16.00 to $15.00 and set a "hold" rating for the company in a report on Monday. Barclays increased their target price on InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research report on Wednesday, February 5th. Finally, Needham & Company LLC reissued a "hold" rating on shares of InMode in a research note on Wednesday, April 9th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $21.25.
Check Out Our Latest Research Report on InMode
InMode Trading Up 0.1 %
INMD stock traded up $0.01 during midday trading on Friday, hitting $14.92. The stock had a trading volume of 870,722 shares, compared to its average volume of 1,178,040. The business has a fifty day moving average price of $17.68 and a two-hundred day moving average price of $17.61. InMode Ltd. has a 1-year low of $13.68 and a 1-year high of $19.85. The firm has a market cap of $1.04 billion, a P/E ratio of 6.35 and a beta of 1.96.
InMode Profile
(
Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
